BridgeBio Pharma (BBIO) EPS (2019 - 2026)
BridgeBio Pharma (BBIO) EPS from Sep 30, 2019 to Mar 31, 2026. The TTM BridgeBio Pharma (BBIO) EPS is -$3.77. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
BridgeBio Pharma (BBIO) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +5.61% |
| 3 Years TTM | +10.72% |
| 5 Years TTM | -3.14% |
| All Time TTM | -2.42% |
Annual EPS change of BridgeBio Pharma (BBIO)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.85 | -77.39% |
| 2025 | -$3.76 | +31.62% |
| 2024 | -$2.86 | -23.37% |
| 2023 | -$3.73 | +15.96% |
| 2022 | -$3.22 | -19.16% |
| 2021 | -$3.98 | -3.27% |
| 2020 | -$4.11 | +76.32% |
| 2019 | -$2.33 | +26.78% |
| 2018 | -$1.84 | N/A |
Comparison BridgeBio Pharma (BBIO) five years EPS CAGR with competitors
BridgeBio Pharma (BBIO) five years EPS CAGR is -3.14%.